PharmaSGP Holding SE
Develops and markets pharmacy-exclusive OTC drugs, primarily with natural ingredients.
PSG | F
Overview
Corporate Details
- ISIN(s):
- DE000A2P4LJ5
- LEI:
- 3912005CZ12PVVCIPT91
- Country:
- Germany
- Address:
- Lochhamer Schlag 1, 82166 Gräfelfing
- Website:
- https://pharmasgp.com/english/
- Sector:
- Manufacturing
Description
PharmaSGP Holding SE is a pharmaceutical company specializing in the development and marketing of a broad portfolio of over-the-counter (OTC) drugs and other healthcare products. The company focuses on pharmacy-exclusive products for chronic indications, primarily utilizing natural active ingredients with a favorable side-effect profile. It holds a market-leading position in several therapeutic areas, particularly in systemic, chemical-free pain remedies with its RubaXX® (rheumatic pain) and Restaxil® (nerve pain) brand families. The portfolio also includes prominent brands such as Baldriparan® (natural sleep aid), Formigran® (migraine), Spalt® (general pain), and DESEO® and NERADIN® (sexual weakness).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-28 17:50 |
FUTRUE increases adequate cash compensation under the squeeze-out
|
English | 8.2 KB | ||
| 2025-09-22 15:15 |
PharmaSGP convenes extraordinary general meeting to resolve on Squeeze-out
|
English | 7.3 KB | ||
| 2025-09-19 14:15 | English | 3.9 KB | |||
| 2025-09-11 09:00 |
PharmaSGP publishes preliminary half-year figures for 2025
|
English | 15.7 KB | ||
| 2025-08-14 12:00 |
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,315 additional shares…
|
English | 6.8 KB | ||
| 2025-08-11 13:00 |
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 39,678 additional share…
|
English | 6.8 KB | ||
| 2025-08-08 11:47 |
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 873 additional shares o…
|
English | 6.8 KB | ||
| 2025-08-07 13:11 |
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,505 additional shares…
|
English | 6.8 KB | ||
| 2025-08-06 16:16 |
PharmaSGP Holding SE: Delisting of PharmaSGP shares from Frankfurt Stock Exchan…
|
English | 7.8 KB | ||
| 2025-08-05 10:48 |
PharmaSGP Holding SE: Michael Rudolf, Tender of 4,169 shares within the public …
|
English | 5.9 KB | ||
| 2025-08-04 13:58 |
PharmaSGP Holding SE: Dr. Clemens Fischer, Tender of a total of 6,062 addition…
|
English | 6.6 KB | ||
| 2025-07-28 17:04 |
PharmaSGP Holding SE publishes joint reasoned statement of the Management Board…
|
English | 9.2 KB | ||
| 2025-07-28 14:11 |
PharmaSGP Holding SE: FUTRUE GmbH, Tender of an additional total of 4,491 share…
|
English | 6.9 KB | ||
| 2025-07-24 15:30 |
PharmaSGP Holding SE: FUTRUE GmbH, buy
|
English | 6.0 KB | ||
| 2025-07-24 14:11 |
FUTRUE GmbH submits request to implement squeeze-out of minority shareholders o…
|
English | 8.2 KB |
Automate Your Workflow. Get a real-time feed of all PharmaSGP Holding SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PharmaSGP Holding SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PharmaSGP Holding SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-06-28 | MVH Beteiligungs- und Beratungs-GmbH | Close relation | Buy | None | 716,750.00 EUR |
| 2021-06-28 | FUTRUE GmbH | Close relation | Buy | None | 6,450,750.00 EUR |
Peer Companies
